home / stock / beat / beat news


BEAT News and Press, Heartbeam Inc. From 05/14/23

Stock Information

Company Name: Heartbeam Inc.
Stock Symbol: BEAT
Market: NASDAQ
Website: heartbeam.com

Menu

BEAT BEAT Quote BEAT Short BEAT News BEAT Articles BEAT Message Board
Get BEAT Alerts

News, Short Squeeze, Breakout and More Instantly...

BEAT - HeartBeam, Inc. (BEAT) Q1 2023 Earnings Call Transcript

2023-05-14 05:21:09 ET HeartBeam, Inc. (BEAT) Q1 2023 Earnings Conference Call May 11, 2023 04.30 PM ET Company Participants Branislav Vajdic - Founder and Chief Executive Officer Rob Eno - President Richard Brounstein - Chief Financial Officer Conference C...

BEAT - InvestorNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2023 Financial Report, Corporate Updates

HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only 3D-vector electrocardiogram ("VECG") platform for heart attack detection anytime, anywhere, is reporting its operational and financial results for the first quarter 2023, the period ended March 31, 2022....

BEAT - HeartBeam reports Q1 results

2023-05-11 16:41:33 ET HeartBeam press release ( NASDAQ: BEAT ): Q1 GAAP EPS of -$0.50. Cash totaled approximately $990K as of March 31, 2023. For further details see: HeartBeam reports Q1 results

BEAT - HeartBeam Reports First Quarter 2023 Financial Results

Closed $26.5 Million with a Public Offering and Registered Direct Offering to Enable Company to Execute on Upcoming Clinical, Regulatory and Commercial Milestones and Extend Cash Runway into Late 2024 Strategic Focus on Becoming the Global Leader in Ambulatory Vectorcardiography, the High...

BEAT - InvestorNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Completes $25M Capital Raise to Achieve Upcoming Milestones, Extend Cash Runway

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform to help physicians detect heart attacks anytime, anywhere as well as diagnose other common heart conditions. The company today announced the ...

BEAT - HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance

HeartBeam to Focus on Becoming the Global Leader in Ambulatory Vectorcardiography, the Highest Resolution ECG Monitoring Platform Funding to Enable Company to Execute on Upcoming Clinical, Regulatory and Commercial Milestones, Extends Cash Runway into Late 2024 HeartBeam to Host C...

BEAT - 6 Disruptive Stocks That Will Benefit From Interest Rate Policy Change

2023-04-13 08:16:04 ET Summary Early commercial stage companies burn cash as they scale. A rising interest rate environment is a headwind for companies burning cash. Numerous advances in technology have created more opportunities to disrupt the normal way to do things. As ...

BEAT - BioMedNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Poised to Offer Timely Solution amid a 'Smoldering Public Health Crisis'

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector electrocardiogram for heart attack detection anytime, anywhere. “A recent study shows that risk factors for cardiovascular (‘CV’) disease are rising among young adults&#x...

BEAT - BioMedNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Poised to Enable Expedited Care for Heart Attack Patients

HeartBeam (NASDAQ: BEAT) is developing the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. “By applying a suite of proprietary algorithms to simplify vector electrocardiography (‘VECG’), the HeartBeam platform will enable patients and thei...

BEAT - HeartBeam Inc. (NASDAQ: BEAT) Focuses on CV Solutions as Study Shows CV Disease Rising Among Young Adults

New data show rising burden of most cardiovascular risk factors among young adults aged 20 to 44 in the U.S. Findings are “extremely concerning” as expert notes “we’re witnessing a smoldering public health crisis” HeartBeam has developed the first and only 3...

Previous 10 Next 10